IL42016A - History of dopamine and their preparation - Google Patents

History of dopamine and their preparation

Info

Publication number
IL42016A
IL42016A IL42016A IL4201673A IL42016A IL 42016 A IL42016 A IL 42016A IL 42016 A IL42016 A IL 42016A IL 4201673 A IL4201673 A IL 4201673A IL 42016 A IL42016 A IL 42016A
Authority
IL
Israel
Prior art keywords
methyl
hydrogen
phenethylamine
methoxylated
propyl7
Prior art date
Application number
IL42016A
Other languages
English (en)
Hebrew (he)
Other versions
IL42016A0 (en
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22918877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL42016(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL42016A0 publication Critical patent/IL42016A0/xx
Publication of IL42016A publication Critical patent/IL42016A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL42016A 1972-04-12 1973-04-12 History of dopamine and their preparation IL42016A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24346672A 1972-04-12 1972-04-12

Publications (2)

Publication Number Publication Date
IL42016A0 IL42016A0 (en) 1973-06-29
IL42016A true IL42016A (en) 1976-05-31

Family

ID=22918877

Family Applications (1)

Application Number Title Priority Date Filing Date
IL42016A IL42016A (en) 1972-04-12 1973-04-12 History of dopamine and their preparation

Country Status (31)

Country Link
JP (2) JPS5825656B2 (ko)
KR (1) KR790000113B1 (ko)
AR (1) AR203822A1 (ko)
AT (1) AT323719B (ko)
AU (1) AU472734B2 (ko)
BE (1) BE798051A (ko)
BG (1) BG23001A3 (ko)
CA (1) CA1018188A (ko)
CH (2) CH580563A5 (ko)
CS (2) CS190448B2 (ko)
CY (1) CY963A (ko)
DD (1) DD107670B3 (ko)
DE (1) DE2317710C2 (ko)
DK (1) DK142750C (ko)
ES (1) ES413639A1 (ko)
FR (1) FR2182947B1 (ko)
GB (1) GB1392674A (ko)
HK (1) HK50178A (ko)
HU (2) HU166213B (ko)
IE (1) IE37511B1 (ko)
IL (1) IL42016A (ko)
KE (1) KE2870A (ko)
MY (1) MY7800381A (ko)
NL (1) NL174459C (ko)
PH (1) PH11041A (ko)
PL (2) PL94207B1 (ko)
RO (2) RO70892A (ko)
SE (1) SE399064B (ko)
SU (1) SU496719A3 (ko)
YU (2) YU36483B (ko)
ZA (1) ZA732136B (ko)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH585693A5 (ko) * 1974-02-08 1977-03-15 Ciba Geigy Ag
US4342692A (en) * 1980-10-20 1982-08-03 Usv Pharmaceutical Corporation Pyrrolidines
NO822514L (no) * 1981-07-22 1983-01-24 Syntex Inc Fremgangsmaate ved fremstilling av terapeutisk virksomme 2,5-substituerte pyrrolidinderivater
JPS6061523A (ja) * 1983-09-16 1985-04-09 Shionogi & Co Ltd 経口用ドブタミン製剤
ZA881076B (en) * 1987-02-24 1989-10-25 Lilly Co Eli Dobutamine salts
JPH0383364U (ko) * 1989-12-18 1991-08-23
EP0613879A4 (en) * 1991-05-20 1995-05-03 Tsumura & Co PHELLODENDRIN ANALOGS AND TYPE IV ALLERGY SUPPRESSOR CONTAINING THEM AS ACTIVE INGREDIENTS.
EP0620208B1 (en) * 1993-04-13 1997-07-09 Duphar International Research B.V Production of dobutamine compounds
DE69404063T2 (de) * 1993-04-13 1998-01-22 Duphar Int Res Herstellung von Dobutamin Verbindungen
WO2004031129A2 (en) 2002-10-03 2004-04-15 New Era Biotech, Ltd. Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
EP1750691B1 (en) 2004-03-26 2016-08-10 Novaremed Ltd. Compounds for treatment of aids and other diseases
GB0804213D0 (en) 2008-03-06 2008-04-16 New Era Biotech Ltd A method of printing or preventing pain
ES2547730T3 (es) 2009-07-31 2015-10-08 Cognition Therapeutics, Inc. Inhibidores del deterioro cognitivo
US8802734B2 (en) 2009-09-09 2014-08-12 Novaremed Limited Method of treating or preventing pain
AU2012298614A1 (en) * 2011-08-25 2014-04-10 Cognition Therapeutics, Inc. Compositions and methods for treating neurodegenerative disease
AU2015210852B2 (en) 2014-01-31 2019-01-24 Cognition Therapeutics, Inc. Isoindoline compositions and methods for treating neurodegenerative disease
CA3061787A1 (en) 2017-05-15 2018-11-22 Cognition Therapeutics, Inc. Compositions for treating neurodegenerative diseases
CN114524734B (zh) * 2021-12-27 2024-04-26 嘉实（湖南）医药科技有限公司 一种盐酸多巴酚丁胺的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2276619A (en) * 1942-03-17 N-phentlaliphatic-dihtoroxyphentnl

Also Published As

Publication number Publication date
NL7305097A (ko) 1973-10-16
HU166213B (ko) 1975-02-28
DD107670B3 (de) 1988-04-06
ES413639A1 (es) 1976-01-16
RO65105A (ro) 1980-01-15
SU496719A3 (ru) 1975-12-25
JPS6221343B2 (ko) 1987-05-12
JPS58131945A (ja) 1983-08-06
MY7800381A (en) 1978-12-31
IE37511B1 (en) 1977-08-03
DK142750C (da) 1981-08-17
BE798051A (fr) 1973-10-11
SE399064B (sv) 1978-01-30
CS190406B2 (en) 1979-05-31
IL42016A0 (en) 1973-06-29
DK142750B (da) 1981-01-12
ZA732136B (en) 1974-03-27
AR203822A1 (es) 1975-10-31
NL174459C (nl) 1984-06-18
DE2317710A1 (de) 1973-10-18
PL94207B1 (ko) 1977-07-30
AU472734B2 (en) 1976-06-03
DE2317710C2 (de) 1983-08-04
KE2870A (en) 1978-09-01
PH11041A (en) 1977-10-25
CY963A (en) 1978-12-22
YU36483B (en) 1984-02-29
CH569691A5 (ko) 1975-11-28
DD107670A5 (de) 1974-08-12
HU167597B (ko) 1975-11-28
YU321279A (en) 1983-04-27
CS190448B2 (en) 1979-05-31
CA1018188A (en) 1977-09-27
JPS5825656B2 (ja) 1983-05-28
FR2182947A1 (ko) 1973-12-14
JPS497237A (ko) 1974-01-22
PL90695B1 (ko) 1977-01-31
KR790000113B1 (en) 1979-03-20
HK50178A (en) 1978-09-15
CH580563A5 (ko) 1976-10-15
NL174459B (nl) 1984-01-16
YU37113B (en) 1984-08-31
GB1392674A (en) 1975-04-30
AU5438573A (en) 1974-10-17
FR2182947B1 (ko) 1976-07-02
BG23001A3 (ko) 1977-05-20
RO70892A (ro) 1982-02-26
AT323719B (de) 1975-07-25
YU97673A (en) 1982-02-25

Similar Documents

Publication Publication Date Title
IL42016A (en) History of dopamine and their preparation
AU594788B2 (en) Pyridine ethanolamine derivatives
US5733936A (en) 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
US6632955B1 (en) Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for preparing the same
EP2285770B1 (en) Process for the synthesis of arformoterol
KR20010094764A (ko) Ｃｎｓ 장해 치료용 모노아민 재흡수 억제제
AU702776B2 (en) Use of aryl-substituted cyclobutylalkylamines for treating obesity
WO2008035358A2 (en) Process for preparing dapoxetine
MXPA02001372A (es) Derivados sustituidos de 2-dialquilaminoalquilbifenilo.
EP1601640A2 (en) Process for preparation of phenethylamine derivatives
CA1061357A (en) Phenylalkylamines
EP1490325B1 (en) Manufacture of phenyl ethylamine compounds, in particular venlafaxine
CA1171086A (en) Substituted 2-phenyl-ethylamines and isosteric compounds, process for their production and use
CA2396304A1 (en) Substituted aminomethyl-phenyl-cyclohexane derivatives
US4028415A (en) Diphenylpropylamines
US2599001A (en) Nu, nu-disubstituted-beta-haloalkylamines
Chandrasekhar et al. Inexpensive protocol for reduction of imines to amines using polymethylhydrosiloxane (PMHS)
US3047628A (en) Benzylamine derivatives
EP0103990A1 (en) Process for making diarylamines
IE60126B1 (en) 3-(2-aminoethyl) indole and -indoline derivatives, process for their preparation and pharmaceutical compositions containing them
US4918242A (en) Novel optically 1,3-phenoxypropylhalides
US4918246A (en) Process for preparing optically active haloalcohols
CN102950025B (zh) 一种亚胺不对称加氢催化剂及其用途
CN101679210B (zh) 旋光性α氨基乙缩醛外消旋化的方法
IE43132B1 (en) Cis-bicyclooctyl-alkyl-amine derivatives